Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Elsevier and Illumina: A meeting of mind and spirit

Posted on August 22nd, 2016 by in Pharma R&D

One of the strongest arguments for using the molecular biology modeling tool Pathway Studio is the rich content underlying its knowledge database. This was driven home recently in a conversation with the DNA/RNA sequencing company Illumina. Continue reading “Elsevier and Illumina: A meeting of mind and spirit” »

Building models for rare diseases

Posted on June 2nd, 2016 by in Pharma R&D

We continue the series of stories about the exciting collaboration between the UK charity Findacure and Elsevier. Findacure’s mission is to empower rare disease patient groups, facilitate treatment Continue reading “Building models for rare diseases” »

Introducing ‘The Hive’

Posted on May 4th, 2016 by in Pharma R&D

Fifty-four percent. That’s the percentage of “all active drugs” sourced via open innovation models for the 12 largest biopharma company pipelines in 2014. Continue reading “Introducing ‘The Hive’” »

Drug Repurposing for Rare Diseases

Posted on April 27th, 2016 by in Pharma R&D

Elsevier’s partnership with a UK charity Findacure started last year with a very touching and inspirational talk from Dr. Nick Sireau, a parent of two children diagnosed with alkaptonuria. Very soon after his first child was born, Nick found himself Continue reading “Drug Repurposing for Rare Diseases” »

  1. 1
  2. 2